• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经尿道膀胱肿瘤切除术后隔夜持续生理盐水冲洗后次日尿细胞学检查结果与膀胱肿瘤复发的相关性。

Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.

机构信息

Department of Urology, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.

Institute of Health Science, Gyeongsang National University, Jinju, Korea.

出版信息

Investig Clin Urol. 2024 May;65(3):279-285. doi: 10.4111/icu.20230284.

DOI:10.4111/icu.20230284
PMID:38714518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11076798/
Abstract

PURPOSE

To investigate the relationship between urine cytology results after overnight continuous saline irrigation (OCSI) following transurethral resection of bladder tumor (TURBT) and bladder tumor recurrence in non-muscle invasive bladder cancer (NMIBC).

MATERIALS AND METHODS

A retrospective study was conducted on patients diagnosed with NMIBC between 2016 and 2020 after undergoing TURBT at our hospital. All patients received OCSI following TURBT and had urine cytology test at postoperative 1 day. Urine cytology was classified into three groups: Negative, low-grade urothelial neoplasm (LGUN)+atypical urothelial cells (AUC), and suspicious for high-grade urothelial carcinoma (SHGUC)+high-grade urothelial carcinoma (HGUC). Recurrence-free survival (RFS) in each group was compared using the Kaplan-Meier method. Univariable and multivariable Cox regression analyses were performed to evaluate independent prognostic factors.

RESULTS

A total of 172 patients were included in this study. Based on urine cytology group (after OCSI), RFS did not reach the median value in the Negative group. In the LGUN+AUC group, the median RFS was 615.00 days. In the SHGUC+HGUC group, the median RFS was 377.00 days. In survival analysis, the Negative group had a longer RFS than the SHGUC+HGUC group (p=0.013). However, Cox regression analysis showed that SHGUC+HGUC was not an independent prognostic factor for recurrence.

CONCLUSIONS

Urine cytology results after OCSI following TURBT in NMIBC were associated with bladder tumor recurrence. Specifically, SHGUC or HGUC in urine cytology after OCSI showed earlier recurrence than negative cases. However, further research is needed to accurately determine whether it is an independent prognostic factor.

摘要

目的

探讨经尿道膀胱肿瘤切除术(TURBT)后行持续生理盐水灌洗(OCSI)后尿细胞学结果与非肌层浸润性膀胱癌(NMIBC)膀胱肿瘤复发的关系。

材料与方法

对 2016 年至 2020 年在我院行 TURBT 诊断为 NMIBC 的患者进行回顾性研究。所有患者在 TURBT 后均行 OCSI,并于术后第 1 天行尿细胞学检查。尿细胞学分为三组:阴性、低级别尿路上皮肿瘤(LGUN)+非典型尿路上皮细胞(AUC)和疑似高级别尿路上皮癌(SHGUC)+高级别尿路上皮癌(HGUC)。采用 Kaplan-Meier 法比较各组无复发生存率(RFS)。采用单变量和多变量 Cox 回归分析评估独立预后因素。

结果

本研究共纳入 172 例患者。根据尿细胞学分组(OCSI 后),阴性组 RFS 未达到中位数。LGUN+AUC 组的中位 RFS 为 615.00 天,SHGUC+HGUC 组的中位 RFS 为 377.00 天。生存分析显示,阴性组 RFS 长于 SHGUC+HGUC 组(p=0.013)。然而,Cox 回归分析显示,SHGUC+HGUC 不是复发的独立预后因素。

结论

NMIBC 行 TURBT 后 OCSI 后的尿细胞学结果与膀胱肿瘤复发相关。具体来说,OCSI 后尿细胞学中出现 SHGUC 或 HGUC 比阴性病例更早复发。然而,需要进一步研究以准确确定其是否为独立的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f847/11076798/ae4605a3eedb/icu-65-279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f847/11076798/ae4605a3eedb/icu-65-279-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f847/11076798/ae4605a3eedb/icu-65-279-g001.jpg

相似文献

1
Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.经尿道膀胱肿瘤切除术后隔夜持续生理盐水冲洗后次日尿细胞学检查结果与膀胱肿瘤复发的相关性。
Investig Clin Urol. 2024 May;65(3):279-285. doi: 10.4111/icu.20230284.
2
Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.经尿道膀胱肿瘤钬激光剜除术后持续生理盐水膀胱冲洗可提高低危和中危非肌层浸润性膀胱癌患者的无复发生存率。
Prog Urol. 2021 May;31(6):316-323. doi: 10.1016/j.purol.2021.01.011. Epub 2021 Mar 2.
3
Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.经尿道膀胱肿瘤切除术(非肌层浸润性膀胱癌)后早期尿细胞学检查的诊断性能和预测能力:一项前瞻性研究。
Urol Oncol. 2020 Dec;38(12):935.e1-935.e8. doi: 10.1016/j.urolonc.2020.06.012. Epub 2020 Jul 9.
4
[A real-world study of the clinical application of the Paris system for reporting urinary cytology in cancer hospital].[巴黎系统在肿瘤医院尿细胞学报告中的临床应用的真实世界研究]
Zhonghua Zhong Liu Za Zhi. 2024 Jul 23;46(7):703-709. doi: 10.3760/cma.j.cn112152-20230731-00049.
5
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.术中上尿路细胞学检查是非肌层浸润性膀胱癌患者上尿路复发的危险因素。
Urol Oncol. 2021 Jan;39(1):75.e9-75.e16. doi: 10.1016/j.urolonc.2020.06.011. Epub 2020 Jul 12.
6
Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.尿细胞学检查作为既往非肌层浸润性膀胱癌患者复发检测常规检查的实用性和成本效益
Korean J Urol. 2014 Oct;55(10):650-5. doi: 10.4111/kju.2014.55.10.650. Epub 2014 Oct 10.
7
Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.使用5-氨基酮戊酸进行光动力诊断与不进行光动力诊断的经尿道非肌层浸润性膀胱癌切除术后疾病复发的比较评估:一项倾向评分匹配分析。
Int J Clin Oncol. 2024 Feb;29(2):205-212. doi: 10.1007/s10147-023-02447-2. Epub 2023 Dec 19.
8
The predictive value of positive and suspicious urine cytology: Are they different?尿细胞学阳性和可疑的预测价值:它们有区别吗?
Diagn Cytopathol. 2020 Nov;48(11):998-1002. doi: 10.1002/dc.24531. Epub 2020 Jun 18.
9
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence?非肌层浸润性膀胱癌随访中联合细胞学/Epichek 检测:有效工具还是无谓花费?
Urol Oncol. 2021 Feb;39(2):131.e17-131.e21. doi: 10.1016/j.urolonc.2020.06.018. Epub 2020 Aug 7.
10
Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C.对于非肌层浸润性膀胱癌患者,经尿道膀胱肿瘤切除术后持续膀胱冲洗两小时与膀胱内灌注丝裂霉素C相比,不能预防复发或进展。
BMC Urol. 2018 Oct 24;18(1):93. doi: 10.1186/s12894-018-0408-6.

引用本文的文献

1
Correlation of shear wave elastography with histopathological grade, tumor stage, and microvessel density in bladder cancer.剪切波弹性成像与膀胱癌组织病理学分级、肿瘤分期及微血管密度的相关性
Investig Clin Urol. 2025 May;66(3):207-214. doi: 10.4111/icu.20250068.

本文引用的文献

1
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.NCCN 指南®洞察:膀胱癌,第 2.2022 版。
J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041.
2
Biomarkers in Bladder Cancer Surveillance.膀胱癌监测中的生物标志物
Front Surg. 2021 Sep 28;8:735868. doi: 10.3389/fsurg.2021.735868. eCollection 2021.
3
Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.经尿道膀胱肿瘤切除术(非肌层浸润性膀胱癌)后早期尿细胞学检查的诊断性能和预测能力:一项前瞻性研究。
Urol Oncol. 2020 Dec;38(12):935.e1-935.e8. doi: 10.1016/j.urolonc.2020.06.012. Epub 2020 Jul 9.
4
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.欧洲泌尿外科学会非肌肉浸润性膀胱癌(TaT1 和原位癌)指南 - 2019 年更新版。
Eur Urol. 2019 Nov;76(5):639-657. doi: 10.1016/j.eururo.2019.08.016. Epub 2019 Aug 20.
5
Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence.经尿道切除非肌层浸润性膀胱癌后进行夜间持续生理盐水冲洗有助于预防早期复发。
Can Urol Assoc J. 2018 Nov;12(11):E480-E483. doi: 10.5489/cuaj.5122. Epub 2018 Jun 8.
6
The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology.巴黎泌尿系统细胞学报告系统:开发标准化术语的探索。
Acta Cytol. 2016;60(3):185-97. doi: 10.1159/000446270. Epub 2016 Jun 18.
7
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.非肌肉浸润性膀胱癌的诊断与治疗:AUA/SUO 指南。
J Urol. 2016 Oct;196(4):1021-9. doi: 10.1016/j.juro.2016.06.049. Epub 2016 Jun 16.
8
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks.烟草烟雾在膀胱癌和肾癌发生中的作用:暴露比较及发病率和死亡率的荟萃分析。
Eur Urol. 2016 Sep;70(3):458-66. doi: 10.1016/j.eururo.2015.06.042. Epub 2015 Jul 3.
9
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.膀胱癌的分子生物学:发病机制和临床多样性的新见解。
Nat Rev Cancer. 2015 Jan;15(1):25-41. doi: 10.1038/nrc3817.
10
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.尿细胞学及其他膀胱癌尿液生物标志物的敏感性和特异性的前瞻性分析。
Urol Oncol. 2015 Feb;33(2):66.e25-31. doi: 10.1016/j.urolonc.2014.06.008. Epub 2014 Jul 15.